UPDATE 3-Massachusetts official challenges Gilead's hepatitis C drug prices
0
Jan 27 (Reuters) - Massachusetts' attorney general is studying whether prices of Gilead Sciences' blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California-based drugmaker.